These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


270 related items for PubMed ID: 17786370

  • 1. Interferon-alpha-induced apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-dependent and -independent manner.
    Yanase N, Kanetaka Y, Mizuguchi J.
    Oncol Rep; 2007 Oct; 18(4):1031-8. PubMed ID: 17786370
    [Abstract] [Full Text] [Related]

  • 2. Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells.
    Oshima K, Yanase N, Ibukiyama C, Yamashina A, Kayagaki N, Yagita H, Mizuguchi J.
    Cytokine; 2001 May 21; 14(4):193-201. PubMed ID: 11448118
    [Abstract] [Full Text] [Related]

  • 3. Requirement of c-Jun NH2-terminal kinase activation in interferon-alpha-induced apoptosis through upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells.
    Yanase N, Hata K, Shimo K, Hayashida M, Evers BM, Mizuguchi J.
    Exp Cell Res; 2005 Oct 15; 310(1):10-21. PubMed ID: 16099454
    [Abstract] [Full Text] [Related]

  • 4. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
    Toomey NL, Deyev VV, Wood C, Boise LH, Scott D, Liu LH, Cabral L, Podack ER, Barber GN, Harrington WJ.
    Oncogene; 2001 Oct 25; 20(48):7029-40. PubMed ID: 11704827
    [Abstract] [Full Text] [Related]

  • 5. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
    Jiang CC, Chen LH, Gillespie S, Kiejda KA, Mhaidat N, Wang YF, Thorne R, Zhang XD, Hersey P.
    Cancer Res; 2007 Jun 15; 67(12):5880-8. PubMed ID: 17575157
    [Abstract] [Full Text] [Related]

  • 6. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
    Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, Nakata K, Ishii N, Eguchi K.
    Oncogene; 2003 Mar 20; 22(11):1653-62. PubMed ID: 12642868
    [Abstract] [Full Text] [Related]

  • 7. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
    Johnsen JI, Pettersen I, Ponthan F, Sveinbjørnsson B, Flaegstad T, Kogner P.
    Int J Oncol; 2004 Dec 20; 25(6):1849-57. PubMed ID: 15547726
    [Abstract] [Full Text] [Related]

  • 8. Interferon-beta-induced activation of c-Jun NH2-terminal kinase mediates apoptosis through up-regulation of CD95 in CH31 B lymphoma cells.
    Takada E, Shimo K, Hata K, Abiake M, Mukai Y, Moriyama M, Heasley L, Mizuguchi J.
    Exp Cell Res; 2005 Apr 01; 304(2):518-30. PubMed ID: 15748896
    [Abstract] [Full Text] [Related]

  • 9. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK.
    Free Radic Biol Med; 2008 Mar 15; 44(6):1055-68. PubMed ID: 18164688
    [Abstract] [Full Text] [Related]

  • 10. Interferon (IFN)-beta induces apoptotic cell death in DHL-4 diffuse large B cell lymphoma cells through tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Oehadian A, Koide N, Mu MM, Hassan F, Islam S, Yoshida T, Yokochi T.
    Cancer Lett; 2005 Jul 08; 225(1):85-92. PubMed ID: 15922860
    [Abstract] [Full Text] [Related]

  • 11. IFN-gamma inhibition of TRAIL-induced IAP-2 upregulation, a possible mechanism of IFN-gamma-enhanced TRAIL-induced apoptosis.
    Park SY, Billiar TR, Seol DW.
    Biochem Biophys Res Commun; 2002 Feb 22; 291(2):233-6. PubMed ID: 11846395
    [Abstract] [Full Text] [Related]

  • 12. Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects.
    Baader E, Toloczko A, Fuchs U, Schmid I, Beltinger C, Ehrhardt H, Debatin KM, Jeremias I.
    Cancer Res; 2005 Sep 01; 65(17):7888-95. PubMed ID: 16140959
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
    Chaturvedi V, Bodner B, Qin JZ, Nickoloff BJ.
    J Dermatol Sci; 2006 Jan 01; 41(1):31-41. PubMed ID: 16289694
    [Abstract] [Full Text] [Related]

  • 15. Fetal-derived trophoblast use the apoptotic cytokine tumor necrosis factor-alpha-related apoptosis-inducing ligand to induce smooth muscle cell death.
    Keogh RJ, Harris LK, Freeman A, Baker PN, Aplin JD, Whitley GS, Cartwright JE.
    Circ Res; 2007 Mar 30; 100(6):834-41. PubMed ID: 17322170
    [Abstract] [Full Text] [Related]

  • 16. Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells.
    Stang MT, Armstrong MJ, Watson GA, Sung KY, Liu Y, Ren B, Yim JH.
    Oncogene; 2007 Sep 27; 26(44):6420-30. PubMed ID: 17452973
    [Abstract] [Full Text] [Related]

  • 17. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP, Chow SC.
    FEBS Lett; 2005 Nov 21; 579(28):6465-72. PubMed ID: 16289096
    [Abstract] [Full Text] [Related]

  • 18. TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-beta in cervical carcinoma cells.
    Vannucchi S, Chiantore MV, Fiorucci G, Percario ZA, Leone S, Affabris E, Romeo G.
    Oncogene; 2005 Apr 07; 24(15):2536-46. PubMed ID: 15735750
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Significant inhibition of TRAIL-mediated fibroblast-like synovial cell apoptosis by IFN-gamma through JAK/STAT pathway by translational regulation.
    Tamai M, Kawakami A, Tanaka F, Miyashita T, Nakamura H, Iwanaga N, Izumi Y, Arima K, Aratake K, Huang M, Kamachi M, Ida H, Origuchi T, Eguchi K.
    J Lab Clin Med; 2006 Apr 07; 147(4):182-90. PubMed ID: 16581346
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.